The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis

Objective  To compare the efficacy and safety of intermittent terbinafine with standard courses of terbinafine and itraconazole for dermatophyte toenail onychomycosis.

[1]  Aditya K. Gupta,et al.  Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes. , 2007, Medical mycology.

[2]  D. A. Santos,et al.  In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole , 2007, Mycoses.

[3]  Daniel de Assis Santos,et al.  Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). , 2007, Journal of medical microbiology.

[4]  E. Warshaw,et al.  Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. , 2005, Journal of the American Academy of Dermatology.

[5]  H. Trau,et al.  Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis , 2004, The Journal of dermatological treatment.

[6]  N. Zaias,et al.  The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. , 2004, Archives of dermatology.

[7]  Aditya K. Gupta,et al.  Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis. , 2003, Clinics in dermatology.

[8]  Aditya K. Gupta,et al.  How to improve cure rates for the management of onychomycosis. , 2003, Dermatologic clinics.

[9]  H. Trau,et al.  Oral terbinafine in the treatment of onychomycosis: a comparison of continuous and extended‐pause regimens , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  B. Sigurgeirsson,et al.  Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. , 2002, Archives of dermatology.

[11]  S. Stubb,et al.  Long‐term results in patients with onychomycosis treated with terbinafine or itraconazole , 2002, The British journal of dermatology.

[12]  A. Akar,et al.  An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis , 2002, The Journal of dermatological treatment.

[13]  E. Warshaw,et al.  Idiopathic aseptic facial granuloma (pyodermite froide du visage): a pediatric entity? , 2001 .

[14]  C. Lynde,et al.  Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. , 2001, Journal of the American Academy of Dermatology.

[15]  E. Warshaw,et al.  Intermittent terbinafine for toenail onychomycosis: is it effective? Results of a randomized pilot trial. , 2001, Archives of dermatology.

[16]  R. Summerbell,et al.  Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients. , 2000, Journal of the American Academy of Dermatology.

[17]  B. Glick,et al.  Onychomycosis treated until the nail is replaced by normal growth or there is failure. , 2000, Archives of dermatology.

[18]  B. Sigurgeirsson,et al.  Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis , 1999 .

[19]  Turjanmaa,et al.  Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison , 1999, The British journal of dermatology.

[20]  E. Evans,et al.  Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. , 1999, BMJ.

[21]  E. Alpsoy,et al.  Intermittent Therapy with Terbinafine for Dermatophyte Toe‐Onychomycosis: A New Approach , 1996, The Journal of dermatology.

[22]  B. Piraccini,et al.  Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. , 1996, Journal of the American Academy of Dermatology.

[23]  L. Millérioux,et al.  Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks. , 1993, Acta dermato-venereologica.

[24]  European Academy of Dermatology and Venereology , 1992 .

[25]  S. Shuster,et al.  Single dose treatment of fungal nail disease , 1992, The Lancet.